革命药品公司
US ˙ NasdaqGS ˙ US76155X1000

介绍

本页面提供了有关 Third Rock Ventures II, L.P. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Third Rock Ventures II, L.P.已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:JNCE / Jounce Therapeutics Inc 10% Owner 2,697,829
US:RVMD / Revolution Medicines, Inc. 10% Owner 0
10% Owner 885,104
US:ALNA / Allena Pharmaceuticals Inc 10% Owner 0
US:GBT / Global Blood Therapeutics Inc. 10% Owner 2,475,191
US:BPMC / Blueprint Medicines Corporation 10% Owner 3,453,753
US:SAGE / Sage Therapeutics, Inc. 10% Owner 2,892,916
如何解读这些图表

以下图表显示了在Third Rock Ventures II, L.P.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

RVMD / Revolution Medicines, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 RVMD / Revolution Medicines, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

RVMD / Revolution Medicines, Inc. Insider Trades
RVMD / Revolution Medicines, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 RVMD / Revolution Medicines, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2021-06-04 RVMD Third Rock Ventures II, L.P. 164,996 30.2300 164,996 30.2300 4,987,829 342 14.5400 -2,588,787 -51.90
2021-06-03 RVMD Third Rock Ventures II, L.P. 378,117 30.2000 378,117 30.2000 11,419,133
2021-05-26 RVMD Third Rock Ventures II, L.P. 1,231,204 30.5300 1,231,204 30.5300 37,588,658
2021-05-25 RVMD Third Rock Ventures II, L.P. 135,000 30.9300 135,000 30.9300 4,175,550

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

RVMD / Revolution Medicines, Inc. Insider Trades
内幕交易历史

该表格显示了由 Third Rock Ventures II, L.P. 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2021-09-17 2021-09-15 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,750,000 2,697,829 -39.35
2021-06-14 2021-06-10 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,500,000 4,447,829 -25.22
2021-06-07 2021-06-04 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -164,996 0 -100.00 30.23 -4,987,829
2021-06-07 2021-06-03 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -378,117 164,996 -69.62 30.20 -11,419,133 4,982,879
2021-05-27 2021-05-25 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -552,520 5,947,829 -8.50 8.00 -4,420,160 47,582,632
2021-05-27 2021-05-26 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -1,231,204 543,113 -69.39 30.53 -37,588,658 16,581,240
2021-05-27 2021-05-25 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -135,000 1,774,317 -7.07 30.93 -4,175,550 54,879,625
2021-03-15 2021-03-11 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,250,000 6,500,349 -16.13
2021-03-03 2021-03-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -1,450,000 7,750,349 -15.76 11.75 -17,037,500 91,066,601
2020-11-23 2020-11-19 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -15,000 9,200,349 -0.16 7.00 -105,075 64,448,445
2020-11-19 2020-11-17 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -15,000 9,215,349 -0.16 7.25 -108,772 66,825,103
2020-11-13 2020-11-11 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 9,230,349 -9.77
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock 		C - Conversion -1,909,317 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series C Preferred Stock 		C - Conversion -49,879 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock 		C - Conversion -342,505 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series A Preferred Stock 		C - Conversion -8,220,641 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock 		C - Conversion 1,909,317 1,909,317
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock 		C - Conversion 8,613,025 9,024,031 2,095.60
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2018-03-07 2018-03-07 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 885,104 -69.32
2017-12-08 2017-12-06 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 2,885,104 -40.94
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -4,629,630 0 -100.00
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Series A Preferred Stock 		C - Conversion -6,122,448 0 -100.00
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Common Stock 		P - Purchase 215,000 2,790,964 8.35 14.00 3,010,000 39,073,496
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Common Stock 		C - Conversion 2,575,964 2,575,964
2017-09-29 2017-09-28 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 4,885,104 -29.05
2017-09-27 2017-09-26 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -400,000 6,885,104 -5.49 43.00 -17,200,000 296,059,472
2017-09-27 2017-09-25 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -201,400 7,285,104 -2.69 43.00 -8,660,200 313,259,472
2017-09-12 2017-09-11 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -20,000 57,651 -25.76 44.25 -885,080 2,551,287
2017-09-12 2017-09-08 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -900 7,486,504 -0.01 42.39 -38,149 317,337,932
2017-09-12 2017-09-08 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -200,350 7,487,404 -2.61 41.00 -8,214,350 306,983,564
2017-06-16 2017-06-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -1,000,000 2,475,191 -28.78
2017-05-19 2017-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 3,475,191 -22.35
2017-05-19 2017-04-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		G - Gift -1,708 163,996 -1.03
2017-05-19 2017-04-11 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		G - Gift -50,000 165,704 -23.18
2017-04-06 2017-04-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -2,000,000 4,475,191 -30.89
2017-04-03 2017-03-30 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -850,000 7,687,754 -9.96
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -10,900 146,208 -6.94 28.73 -313,146 4,200,410
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -7,279 157,108 -4.43 27.69 -201,526 4,349,692
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -27,115 164,387 -14.16 26.95 -730,803 4,430,558
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 285,713 -77.78 25.50 -25,500,000 7,285,682
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 285,713 -77.78 25.50 -25,500,000 7,285,682
2017-02-28 2017-02-27 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other X -1,000,000 3,453,753 -22.45
2017-02-09 2017-02-07 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -1,000,000 4,453,753 -18.34 35.28 -35,275,000 157,106,137
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -11,250,000 0 -100.00
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -35,750,000 0 -100.00
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		C - Conversion 3,048,780 3,048,780
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		C - Conversion 9,688,344 10,230,349 1,787.50
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2016-12-16 2016-12-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -2,000,000 7,475,191 -21.11
2016-12-01 2016-11-29 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -850,000 8,537,754 -9.05
2016-11-16 2016-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 1,939,449 -34.02 19.36 -19,360,000 37,547,733
2016-11-16 2016-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 1,285,713 -43.75 19.36 -19,360,000 24,891,404
2016-11-07 2016-11-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other -2,000,000 10,475,191 -16.03
2016-08-19 2016-08-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 2,892,916 -25.69
2016-05-18 2016-05-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		S - Sale -850,000 3,892,916 -17.92 31.25 -26,562,500 121,653,625
2016-04-15 2016-04-14 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -1,200,000 5,453,753 -18.03
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -220,387 0 -100.00
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 220,387 220,387
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -739,306 6,653,753 -10.00
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 15,986 65,227 32.46
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 15,986 65,227 32.46
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -109,832 0 -100.00
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 109,832 109,832
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,700,000 4,742,916 -26.39
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Series A Preferred Stock 		C - Conversion -5,500,000 0 -100.00
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Series A Preferred Stock 		C - Conversion -32,500,000 0 -100.00
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Common Stock 		C - Conversion 1,496,598 1,496,598
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Common Stock 		C - Conversion 8,843,537 9,387,754 1,625.00
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-08-19 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -41,663,168 0 -100.00
2015-08-19 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		C - Conversion 11,903,763 12,475,191 2,083.16
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 21,910 49,241 80.17
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 21,910 49,241 80.17
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -150,546 0 -100.00
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 150,546 150,546
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -2,330,157 6,442,916 -26.56
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 9,403 27,331 52.45
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 9,402 27,330 52.44
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -64,607 0 -100.00
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 64,607 64,607
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 8,773,073 -10.23
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series C Preferred Stock 		C - Conversion -1,328,502 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series B Preferred Stock 		C - Conversion -7,833,333 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series A Preferred Stock 		C - Conversion -30,000,000 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 241,545 7,393,059 3.38
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 1,424,242 7,151,514 24.87
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 5,454,545 5,727,272 2,000.00
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -81,094 0 -100.00
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 81,094 81,094
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,255,177 9,773,073 -11.38
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -42,173 0 -100.00
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 42,173 42,173
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -652,758 11,028,250 -5.59
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series C Preferred Stock 		C - Conversion -295,194 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series B Preferred Stock 		C - Conversion -2,499,999 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -32,500,000 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 93,712 11,681,008 0.81
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 793,650 11,587,296 7.35
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 10,317,457 10,793,646 2,166.67
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）